Converting patients intolerant of simvastatin to atorvastatin is a safe practice and associated with significant improvement in lipid control and less creatine kinase elevation

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Krasuski, RA; Doeppenschmidt, DL; Beck, RL; Henry, JS; Thompson, CM

Published Date

  • March 19, 2003

Published In

Volume / Issue

  • 41 / 6

Start / End Page

  • 245A - 245A

International Standard Serial Number (ISSN)

  • 0735-1097